Cogent Biosciences (COGT) Non-cash Items (2018 - 2026)

Cogent Biosciences' Non-cash Items history runs 9 years deep, the most recent figure standing at $44.6 million for Q1 2026.

• In Q1 2026, Non-cash Items rose 437.35% year-over-year to $44.6 million; the TTM figure through Mar 2026 stood at $44.6 million (up 437.35% YoY), while the FY2025 annual figure was $21.1 million, up 10450.0% from the prior year.
• Non-cash Items was $44.6 million for Q1 2026 at Cogent Biosciences, up from $21.1 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $55.6 million in Q1 2024 to a low of $200000.0 in Q4 2024.
• Historically, Non-cash Items has averaged $25.2 million across 5 years, with a median of $12.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-cash Items plunged 99.45% in 2023, then soared 18433.33% in 2024.
• A 5-year view of Non-cash Items shows it stood at $47.5 million in 2022, then tumbled by 82.22% to $8.4 million in 2023, then tumbled by 97.63% to $200000.0 in 2024, then jumped by 10450.0% to $21.1 million in 2025, then jumped by 111.37% to $44.6 million in 2026.
• The last three Non-cash Items figures came in at $44.6 million (Q1 2026), $21.1 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.